Loader

Pathways

PathWhiz ID Pathway Meta Data

PW176345

Pw176345 View Pathway
metabolic

Nebivolol Predicted Metabolism Pathway

Homo sapiens
Metabolites of sildenafil are predicted with biotransformer.

PW127653

Pw127653 View Pathway
drug action

Necitumumab Action Pathway

Homo sapiens
Necitumumab is an intravenously administered recombinant monoclonal IgG1 antibody used to treat metastatic squamous non-small cell lung cancer. It is approved for use in combination with cisplatin and gemcitabine. It blocks other ligands of the EGFR from binding and activating numerous signalling cascades to promote cell growth, proliferation, and differentiation. The main cascades that are affected are the MAPK signalling cascade, which affects the synthesis of DNA for proliferation and differentiation and the PI3K/AKT1 signalling cascade which also affects proliferation but also controls apoptosis. MAPK is activated through the epidermal growth factor receptor on the cell membrane and goes on to phosphorylate and regulate the activities of several transcription factors affecting cellular growth and proliferation. The PI3K/AKT1 signalling cascade is apart of the PI3K/AKT1/mTOR pathway which is an intracellular signalling pathway that also helps regulate the cell cycle. This signalling cascade can affect the regulation and activity of transcription factors as well. In cancer, the PI3K/AKT1/mTOR is overactive reducing apoptosis and allowing excessive cellular proliferation.

PW132239

Pw132239 View Pathway
metabolic

Nedaplatin Drug Metabolism

Homo sapiens
Nedaplatin is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Nedaplatin passes through the liver and is then excreted from the body mainly through the kidney.

PW146590

Pw146590 View Pathway
drug action

Nedaplatin Drug Metabolism Action Pathway

Homo sapiens

PW144828

Pw144828 View Pathway
drug action

Nedocromil Drug Metabolism Action Pathway

Homo sapiens

PW145237

Pw145237 View Pathway
drug action

Nefazodone Drug Metabolism Action Pathway

Homo sapiens

PW132524

Pw132524 View Pathway
metabolic

Nefopam Drug Metabolism

Homo sapiens
Nefopam is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Nefopam passes through the liver and is then excreted from the body mainly through the kidney.

PW146511

Pw146511 View Pathway
drug action

Nefopam Drug Metabolism Action Pathway

Homo sapiens

PW128252

Pw128252 View Pathway
drug action

Nelarabine Action Pathway

Homo sapiens
Nelarabine is an antineoplastic agent from the nucleoside analog drug class. This drug is indicated in the treatment of T-cell lymphoblastic leukemia, particularly T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL), in both adult and pediatric patients whose disease has not responded to or has relapsed following at least two chemotherapy regimens. At the structure level of this molecule, it is a prodrug of the cytotoxic deoxyguanosine analog 9-ß-D-arabinofuranosylguanine (ara-G). Before entering the cells, it is metabolized by adenosine deaminase (ADA) to ara-G. The molecule then enters the cell to be phosphorylated three times, resulting in the formation of ara-G triphosphate (ara-GTP). Ara-GTP is the molecule with the cytotoxic activity. Since T lymphoblasts have a higher expression of deoxycytidine kinase, ara-G accumulates in higher quantities in T cells over B cells, thus showing higher toxicity to T lymphoblasts. Since ara-GTP accumulates in leukemic blasts, it will incorporate the DNA to exert its S phase-specific cytotoxic effects. This activity leads to the apoptosis of the cell. As a nucleoside analog, ara-GTP competes with endogenous deoxyGTP (dGTP) for incorporation into DNA. The mechanism of action that leads to apoptosis is not well understood. It is thought that the inclusion of ara-GTP into the DNA strand can impair proper DNA repair processes, leading to inhibition of DNA elongation, apoptosis, and cellular destruction. It is anticipated that overdosage of this drug result in severe neurotoxicity, myelosuppression, and potential death. Nelarabine is administered as an intravenous injection.

PW145356

Pw145356 View Pathway
drug action

Nelarabine Drug Metabolism Action Pathway

Homo sapiens